NOC

Prezzo Northrop Grumman Corp

Closed
NOC
$690,50
-$5,29(-0,76%)

*Data last updated: 2026-04-08 00:42 (UTC+8)

As of 2026-04-08 00:42, Northrop Grumman Corp (NOC) is priced at $690,50, with a total market cap of $97,99B, a P/E ratio of 19,56, and a dividend yield of 1,33%. Today, the stock price fluctuated between $687,83 and $696,69. The current price is 0,38% above the day's low and 0,88% below the day's high, with a trading volume of 513,97K. Over the past 52 weeks, NOC has traded between $663,90 to $765,58, and the current price is -9,80% away from the 52-week high.

NOC Key Stats

Yesterday's Close$695,79
Market Cap$97,99B
Volume513,97K
P/E Ratio19,56
Dividend Yield (TTM)1,33%
Dividend Amount$2,31
Diluted EPS (TTM)29,26
Net Income (FY)$4,18B
Revenue (FY)$41,95B
Earnings Date2026-04-21
EPS Estimate6,04
Revenue Estimate$9,75B
Shares Outstanding140,84M
Beta (1Y)0.046
Ex-Dividend Date2026-02-23
Dividend Payment Date2026-03-11

About NOC

Northrop Grumman Corporation operates as an aerospace and defense company worldwide. The company's Aeronautics Systems segment designs, develops, manufactures, integrates, and sustains aircraft systems. This segment also offers unmanned autonomous aircraft systems, including high-altitude long-endurance strategic ISR systems and vertical take-off and landing tactical ISR systems; and strategic long-range strike aircraft, tactical fighter and air dominance aircraft, and airborne battle management and command and control systems. Its Defense Systems segment designs, develops, and produces weapons and mission systems. It offers products and services, such as integrated battle management systems, weapons systems and aircraft, and mission systems. This segment also provides command and control and weapons systems, including munitions and missiles; precision strike weapons; propulsion, such as air-breathing and hypersonic systems; gun systems and precision munitions; life cycle service and support for software, weapons systems, and aircraft; and logistics support, sustainment, operation, and modernization for air, sea, and ground systems. The company's Mission Systems segment offers cyber, command, control, communications and computers, intelligence, surveillance, and reconnaissance systems; radar, electro-optical/infrared and acoustic sensors; electronic warfare systems; advanced communications and network systems; cyber solutions; intelligence processing systems; navigation; and maritime power, propulsion, and payload launch systems. This segment also provides airborne multifunction sensors; maritime/land systems and sensors; navigation, targeting, and survivability solutions; and networked information solutions. Its Space Systems segment offers satellites and payloads; ground systems; missile defense systems and interceptors; launch vehicles and related propulsion systems; and strategic missiles. The company was founded in 1939 and is based in Falls Church, Virginia.
SectorIndustrials
IndustryAerospace & Defense
CEOKathy J. Warden
HeadquartersFalls Church,VA,US
Employees (FY)95,00K
Average Revenue (1Y)$441,62K
Net Income per Employee$44,02K

Northrop Grumman Corp (NOC) FAQ

What's the stock price of Northrop Grumman Corp (NOC) today?

x
Northrop Grumman Corp (NOC) is currently trading at $690,50, with a 24h change of -0,76%. The 52-week trading range is $663,90–$765,58.

What are the 52-week high and low prices for Northrop Grumman Corp (NOC)?

x

What is the price-to-earnings (P/E) ratio of Northrop Grumman Corp (NOC)? What does it indicate?

x

What is the market cap of Northrop Grumman Corp (NOC)?

x

What is the most recent quarterly earnings per share (EPS) for Northrop Grumman Corp (NOC)?

x

Should you buy or sell Northrop Grumman Corp (NOC) now?

x

What factors can affect the stock price of Northrop Grumman Corp (NOC)?

x

How to buy Northrop Grumman Corp (NOC) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Hot Posts su Northrop Grumman Corp (NOC)

MaticHoleFiller

MaticHoleFiller

04-06 09:53
>   炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!   本报记者金婉霞   2026年第二季度刚刚“开局”,创新药板块实现领跑。截至4月2日收盘,Wind资讯创新药指数4月1日和4月2日的累计涨幅达6.22%;港股创新药板块涨幅更加明显,恒生港股通创新药指数累计上涨9.11%。   本轮行情或由基本面驱动。Wind资讯数据显示,截至3月底,已有113家在港上市的生物医药企业陆续披露2025年财报,其中72家生物医药企业实现了营收正增长,占比达63.72%,较2024年提升5.10个百分点;其中,有10家企业营收同比增幅超100%(2024年为8家),有13家企业实现扭亏为盈(2024年为10家)。   “2025年,港股生物医药企业中实现营收增长的企业数量和比例较2024年均有所提升,行业整体复苏;同时,高增长企业数量增加,部分创新药企商业化进程加速,业绩爆发力明显增强。”一位行业分析师对《证券日报》记者表示。   一方面,传统制药企业在经历集采阵痛后,加速向创新药转型,2025财年的数据显示,部分企业的收入结构持续调整,来自创新药的营业收入实现稳定增长。中国生物制药有限公司(以下简称“中国生物制药”)在报告期实现创新产品收入152.2亿元,同比增长26.2%,2023年至2025年的年复合增长率超24%。   创新药收入同比增速喜人的还有翰森制药集团有限公司。2025年,该公司由创新药与合作产品销售产生的收入达123.54亿元,同比增长30.4%,创新产品占该公司总收入的比重提升至82.2%。先声药业集团有限公司营业收入中逾八成也由创新药销售收入贡献。2025年,该公司创新药收入63.04亿元,占总收入的比例提升至81.5%,创历史新高。   另一方面,创新型药企则不断发挥创新的长板优势,通过对外授权、进医保等方式优化现金流,不少企业营收大幅增长,部分企业实现扭亏。   2025年对信达生物制药(以下简称“信达生物”)来说是“具有里程碑意义”的一年。该年度,信达生物的18款上市产品中有12款纳入医保,推动产品收入增长44.6%;该公司还首次实现了全年盈利,净利润为8.14亿元。诺诚健华医药有限公司(以下简称“诺诚健华”)因奥布替尼等产品销售放量及潜在授权收入增长,总收入同比增长135.27%并实现年度盈利。2025年,康方生物科技(开曼)有限公司的全部产品所有适应症被纳入国家医保,全年新药销售收入达30.33亿元,同比增长51%。虽仍未实现盈利,但该公司创始人、董事长、总裁兼首席执行官夏瑜认为,企业已在新药商业化、临床开发全球化布局与拓展、药物创新研发体系和企业机制体系实现了“全方位跨越”。   良好的发展势头下,不少上市公司管理层选择回购增持,以“真金白银”展示信心。港交所最新权益披露资料显示,3月底,中国生物制药获执行董事谢炳增持该公司349.6万股,该公司董事会主席谢其润增持174.8万股。Wind资讯数据进一步显示,截至4月2日,包括中国生物制药、诺诚健华在内的30家港股生物医药企业已进行了股份回购。   摩根大通大中华区医疗健康行业研究主管黄旸对《证券日报》记者表示,摩根大通依然看好创新药。“首先,创新药板块基本面强劲,对外授权交易屡创新高、趋势向好;其次,部分子板块自2025年第四季度起开始回调,估值已较2025年的高位水平明显降低;第三,2026年《政府工作报告》首次将生物医药列为国家打造的‘新兴支柱产业’之一,未来,行业有望获得政策的进一步支持。”黄旸表示,建议投资者或可关注创新药、医药研发制造外包服务(CXO)及医疗服务等子板块。   (文章来源:证券日报) 新浪声明:此消息系转载自新浪合作媒体,新浪网登载此文出于传递更多信息之目的,并不意味着赞同其观点或证实其描述。文章内容仅供参考,不构成投资建议。投资者据此操作,风险自担。 海量资讯、精准解读,尽在新浪财经APP
0
0
0
0
Engin1979

Engin1979

2 ore fa
#OilPricesRise Petrol Prices Are Rising… And This Might Not Be Good News for Crypto There’s a quiet but critical movement happening in the markets: 👉 oil prices are on the rise Most people are ignoring it. But this movement: 👉 could impact all financial markets 📊 The Visible Signs • Oil prices broke upward • Energy costs are starting to increase • Inflation expectations are being discussed again This is not just a commodity news. 👉 macro signal 🧠 Why Is It Important? When oil prices rise: • production costs increase • inflation pressure intensifies • central banks stay tighter longer 👉 this also affects risky assets ⚠️ Impact on Crypto The crypto market generally: 👉 grows with liquidity But if oil rises: • interest rate cuts may be delayed • the dollar could strengthen • risk appetite may decrease 👉 in this scenario, crypto faces pressure 🔥 But Not Everything Is Negative In some cases: • inflation increases • distrust in currencies 👉 can strengthen Bitcoin as an “alternative” In other words: 👉 the impact is not always one-way 🌍 The Big Picture Currently, there are two forces at play in the market: 🟢 liquidity expectations 🔴 inflation pressure Oil rising: 👉 could be the breaking point of this balance 🧩 Scenario 🔴 Negative Scenario • oil continues to rise • inflation increases • interest rates stay high 👉 crypto faces suppression 🟢 Positive Scenario • oil remains stable • the market adapts • BTC strengthens as an alternative 👉 crypto recovers 🎯 Conclusion Oil is not just energy: 👉 it’s a hidden driver of market direction 🔥 Question Oil prices rising: 🟢 strengthen Bitcoin 🔴 suppress crypto 💬 Which side are you on? ‍#Oil $GT $NOC $TAC
1
0
0
0
Surrealist5N1K

Surrealist5N1K

4 ore fa
#OilPricesRise Petrol Yükseliyor… Ve Bu Kripto İçin İyi Haber Olmayabilir Piyasalarda sessiz ama kritik bir hareket var: 👉 petrol fiyatları yükselişte Çoğu kişi bunu görmezden geliyor. Ama bu hareket: 👉 tüm finansal piyasaları etkileyebilir 📊 Görünürde Olan • Petrol fiyatı yukarı yönlü kırılım yaptı • Enerji maliyetleri artmaya başladı • Piyasada enflasyon beklentisi yeniden konuşuluyor Bu sadece emtia haberi değil. 👉 makro sinyal 🧠 Neden Önemli? Petrol fiyatı arttığında: • üretim maliyetleri yükselir • enflasyon baskısı artar • merkez bankaları daha sıkı kalır 👉 bu da riskli varlıkları etkiler ⚠️ Kriptoya Etkisi Kripto piyasası genelde: 👉 likidite ile büyür Ama petrol yükselirse: • faiz indirimi gecikebilir • dolar güçlenebilir • risk iştahı düşebilir 👉 bu senaryoda kripto baskı görür 🔥 Ama Her Şey Negatif Değil Bazı durumlarda: • enflasyon artışı • para birimlerine güvensizlik 👉 Bitcoin’i “alternatif” olarak güçlendirebilir Yani: 👉 etki her zaman tek yönlü değil 🌍 Büyük Resim Şu an piyasada aynı anda 2 güç var: 🟢 likidite beklentisi 🔴 enflasyon baskısı Petrol yükselişi: 👉 bu dengenin kırılma noktası olabilir 🧩 Senaryo 🔴 Negatif Senaryo • petrol yükselmeye devam eder • enflasyon artar • faizler yüksek kalır 👉 kripto baskılanır 🟢 Pozitif Senaryo • petrol stabil kalır • piyasa adapte olur • BTC alternatif olarak güçlenir 👉 kripto toparlanır 🎯 Sonuç Petrol sadece enerji değil: 👉 piyasaların gizli yön belirleyicisi 🔥 Soru Petrol yükselişi: 🟢 Bitcoin’i güçlendirir 🔴 Kriptoyu baskılar 💬 Sen hangi taraftasın? ‍#Oil $GT $NOC $TAC
4
3
0
0